Correction

Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)

LANCET NEUROLOGY (2009)

Volume 8, Issue 11, Pages 981-981

DOI: 10.1016/S1474-4422(08)70167-4

Click your name to claim this paper and add it to your profile.